BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chung MK, Shemanski L, Sherman DG, Greene HL, Hogan DB, Kellen JC, Kim SG, Martin LW, Rosenberg Y, Wyse DG. Functional Status in Rate- Versus Rhythm-Control Strategies for Atrial Fibrillation. Journal of the American College of Cardiology 2005;46:1891-9. [DOI: 10.1016/j.jacc.2005.07.040] [Cited by in Crossref: 107] [Cited by in F6Publishing: 87] [Article Influence: 6.3] [Reference Citation Analysis]
Number Citing Articles
1 Heist EK, Mansour M, Ruskin JN. Rate control in atrial fibrillation: targets, methods, resynchronization considerations. Circulation. 2011;124:2746-2755. [PMID: 22155996 DOI: 10.1161/circulationaha.111.019919] [Cited by in Crossref: 25] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
2 Sepehri Shamloo A, Dagres N, Müssigbrodt A, Stauber A, Kircher S, Richter S, Dinov B, Bertagnolli L, Husser-bollmann D, Bollmann A, Hindricks G, Arya A. Atrial Fibrillation and Cognitive Impairment: New Insights and Future Directions. Heart, Lung and Circulation 2020;29:69-85. [DOI: 10.1016/j.hlc.2019.05.185] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 9.0] [Reference Citation Analysis]
3 Sethi NJ, Feinberg J, Nielsen EE, Safi S, Gluud C, Jakobsen JC. The effects of rhythm control strategies versus rate control strategies for atrial fibrillation and atrial flutter: A systematic review with meta-analysis and Trial Sequential Analysis. PLoS One 2017;12:e0186856. [PMID: 29073191 DOI: 10.1371/journal.pone.0186856] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 4.4] [Reference Citation Analysis]
4 Lafuente-Lafuente C, Longas-Tejero MA, Bergmann JF, Belmin J. Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation. Cochrane Database Syst Rev. 2012;5:CD005049. [PMID: 22592700 DOI: 10.1002/14651858.cd005049.pub3] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 2.7] [Reference Citation Analysis]
5 Bottoni N, Tritto M, Ricci R, Accogli M, Di Biase M, Iacopino S, Iori M, Themistoclakis S, Sitta N, Spadacini G, De Ponti R, Brignole M; on behalf of the SITAF investigators. Adherence to guidelines for atrial fibrillation management of patients referred to cardiology departments: Studio Italiano multicentrico sul Trattamento della Fibrillazione Atriale (SITAF). Europace 2010;12:1070-7. [DOI: 10.1093/europace/euq158] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
6 Cohen M, Naccarelli GV. Pathophysiology and Disease Progression of Atrial Fibrillation: Importance of Achieving and Maintaining Sinus Rhythm. Journal of Cardiovascular Electrophysiology 2008;19:885-90. [DOI: 10.1111/j.1540-8167.2008.01134.x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
7 Khan MH, Rochlani Y, Aronow WS. Efficacy and safety of dronedarone in the treatment of patients with atrial fibrillation. Expert Opinion on Drug Safety 2017;16:1407-12. [DOI: 10.1080/14740338.2017.1387246] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
8 Liao Y, Liao J, Lo L, Lin Y, Chang S, Hu Y, Chao T, Chung F, Tuan T, Te ALD, Walia R, Yamada S, Lin C, Lin C, Chang Y, Allamsetty S, Yu W, Huang J, Wu T, Chen S. Left Atrial Size and Left Ventricular End-Systolic Dimension Predict the Progression of Paroxysmal Atrial Fibrillation After Catheter Ablation: Predictors of AF Progression After Ablation. J Cardiovasc Electrophysiol 2017;28:23-30. [DOI: 10.1111/jce.13115] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
9 Pratola C, Baldo E, Notarstefano P, Ferrari R. Radiofrequency catheter ablation to cure atrial fibrillation: may be a wrong target. J Cardiovasc Med (Hagerstown) 2007;8:718-9. [PMID: 17700402 DOI: 10.2459/JCM.0b013e3280101de8] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
10 Lafuente-Lafuente C, Valembois L, Bergmann JF, Belmin J. Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation. Cochrane Database Syst Rev 2015;:CD005049. [PMID: 25820938 DOI: 10.1002/14651858.CD005049.pub4] [Cited by in Crossref: 40] [Cited by in F6Publishing: 39] [Article Influence: 5.7] [Reference Citation Analysis]
11 Madhavan M, Graff-Radford J, Piccini JP, Gersh BJ. Cognitive dysfunction in atrial fibrillation. Nat Rev Cardiol 2018;15:744-56. [PMID: 30275499 DOI: 10.1038/s41569-018-0075-z] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 10.7] [Reference Citation Analysis]
12 Henrard V, Ducharme A, Khairy P, Gisbert A, Roy D, Levesque S, Talajic M, Thibault B, Racine N, White M, Guerra PG, Tardif JC; AF-CHF investigators. Cardiac remodeling with rhythm versus rate control strategies for atrial fibrillation in patients with heart failure: insights from the AF-CHF echocardiographic sub-study. Int J Cardiol 2013;165:430-6. [PMID: 21917326 DOI: 10.1016/j.ijcard.2011.08.077] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
13 Berisso MZ, Fabbri G, Gonzini L, Caruso D, Fontanella A, Pellegrini F, Silvestri N, Vincenti A, Mathieu G, Di Pasquale G; ATA-AF Investigators. Antiarrhythmic strategies in patients with atrial fibrillation managed by cardiologists and internists: Antithrombotic Agents in Atrial Fibrillation (ATA-AF) survey. J Cardiovasc Med (Hagerstown) 2014;15:626-35. [PMID: 24978662 DOI: 10.2459/JCM.0000000000000110] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
14 Velu JF, Kortlandt FA, Hendriks T, Schurer RAJ, van Boven AJ, Koch KT, Vis MM, Henriques JP, Piek JJ, Van den Branden BJL, Schaap J, Rensing BJ, Swaans MJ, Bouma BJ, Van der Heyden JAS, Baan J Jr. Comparison of Outcome After Percutaneous Mitral Valve Repair With the MitraClip in Patients With Versus Without Atrial Fibrillation. Am J Cardiol 2017;120:2035-40. [PMID: 29033048 DOI: 10.1016/j.amjcard.2017.08.022] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 3.2] [Reference Citation Analysis]
15 Khaykin Y, Shamiss Y. Cost considerations in the management of atrial fibrillation - impact of dronedarone. Clinicoecon Outcomes Res 2012;4:67-78. [PMID: 22427725 DOI: 10.2147/CEOR.S16675] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
16 Guglin M, Chen R, Curtis AB. Sinus rhythm is associated with fewer heart failure symptoms: Insights from the AFFIRM trial. Heart Rhythm 2010;7:596-601. [DOI: 10.1016/j.hrthm.2010.01.003] [Cited by in Crossref: 39] [Cited by in F6Publishing: 30] [Article Influence: 3.3] [Reference Citation Analysis]
17 Musco S, Conway EL, Kowey PR. Drug Therapy for Atrial Fibrillation. Medical Clinics of North America 2008;92:121-41. [DOI: 10.1016/j.mcna.2007.08.002] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
18 Dietzel J, Haeusler KG, Endres M. Does atrial fibrillation cause cognitive decline and dementia? EP Europace 2018;20:408-19. [DOI: 10.1093/europace/eux031] [Cited by in Crossref: 50] [Cited by in F6Publishing: 45] [Article Influence: 10.0] [Reference Citation Analysis]
19 Steinberg BA, Holmes DN, Ezekowitz MD, Fonarow GC, Kowey PR, Mahaffey KW, Naccarelli G, Reiffel J, Chang P, Peterson ED, Piccini JP. Rate versus rhythm control for management of atrial fibrillation in clinical practice: results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry. Am Heart J 2013;165:622-9. [PMID: 23537981 DOI: 10.1016/j.ahj.2012.12.019] [Cited by in Crossref: 50] [Cited by in F6Publishing: 41] [Article Influence: 5.6] [Reference Citation Analysis]
20 Wyse DG. Cardioversion of Atrial Fibrillation for Maintenance of Sinus Rhythm: A Road to Nowhere. Circulation 2009;120:1444-52. [DOI: 10.1161/circulationaha.109.884387] [Cited by in Crossref: 13] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
21 Tischer TS, Nitschke D, Krause I, Kundt G, Öner A, D'Ancona G, Şafak E, Ince H, Ortak J, Caglayan E. Prevalence and Progression of Cognitive Impairment in Atrial Fibrillation Patients after Treatment with Catheter Ablation or Drug Therapy. Cardiol Res Pract 2019;2019:7216598. [PMID: 31915546 DOI: 10.1155/2019/7216598] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
22 Hui DS, Morley JE, Mikolajczak PC, Lee R. Atrial fibrillation: A major risk factor for cognitive decline. Am Heart J. 2015;169:448-456. [PMID: 25819850 DOI: 10.1016/j.ahj.2014.12.015] [Cited by in Crossref: 56] [Cited by in F6Publishing: 53] [Article Influence: 8.0] [Reference Citation Analysis]
23 Dillon P, Ghanbari H. Diagnostic Evaluation and Follow-Up of Patients with Atrial Fibrillation. Heart Fail Clin 2016;12:179-91. [PMID: 26968664 DOI: 10.1016/j.hfc.2015.08.015] [Reference Citation Analysis]
24 Zimetbaum P, Falk RH. Atrial Fibrillation. Cardiovascular Therapeutics: A Companion to Braunwald's Heart Disease. Elsevier; 2013. pp. 372-82. [DOI: 10.1016/b978-1-4557-0101-8.00020-5] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
25 Jozwiak A, Guzik P, Mathew A, Wykretowicz A, Wysocki H. Association of Atrial Fibrillation and Focal Neurologic Deficits With Impaired Cognitive Function in Hospitalized Patients ≥65 Years of Age. The American Journal of Cardiology 2006;98:1238-41. [DOI: 10.1016/j.amjcard.2006.05.058] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 1.8] [Reference Citation Analysis]
26 Shah AD, Merchant FM, Delurgio DB. Atrial Fibrillation and Risk of Dementia/Cognitive Decline. J Atr Fibrillation 2016;8:1353. [PMID: 27909476 DOI: 10.4022/jafib.1353] [Cited by in F6Publishing: 10] [Reference Citation Analysis]
27 Krishnamoorthy S, Lip GY. How safe is the antiarrhythmic drug therapy in atrial fibrillation? Europace 2009;11:837-9. [PMID: 19546182 DOI: 10.1093/europace/eup170] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
28 Valembois L, Audureau E, Takeda A, Jarzebowski W, Belmin J, Lafuente-Lafuente C. Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation. Cochrane Database Syst Rev 2019;9:CD005049. [PMID: 31483500 DOI: 10.1002/14651858.CD005049.pub5] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 3.7] [Reference Citation Analysis]
29 Dillon P, Ghanbari H. Diagnostic evaluation and follow-up of patients with atrial fibrillation. Cardiol Clin 2014;32:507-19. [PMID: 25443233 DOI: 10.1016/j.ccl.2014.07.008] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
30 Sardar MR, Saeed W, Kowey PR. Antiarrhythmic Drug Therapy for Atrial Fibrillation. Cardiology Clinics 2014;32:533-49. [DOI: 10.1016/j.ccl.2014.07.012] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
31 Tse H, Wong K, Siu C, Tang M, Tsang V, Ho W, Lau C. Impacts of ventricular rate regularization pacing at right ventricular apical vs. septal sites on left ventricular function and exercise capacity in patients with permanent atrial fibrillation. Europace 2009;11:594-600. [DOI: 10.1093/europace/eup087] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
32 Ding M, Qiu C. Atrial Fibrillation, Cognitive Decline, and Dementia: an Epidemiologic Review. Curr Epidemiol Rep 2018;5:252-61. [PMID: 30148041 DOI: 10.1007/s40471-018-0159-7] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 4.8] [Reference Citation Analysis]
33 Sardar MR, Saeed W, Kowey PR. Antiarrhythmic Drug Therapy for Atrial Fibrillation. Heart Fail Clin 2016;12:205-21. [PMID: 26968666 DOI: 10.1016/j.hfc.2015.08.017] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 3.2] [Reference Citation Analysis]
34 Rivard L, Khairy P. Mechanisms, Clinical Significance, and Prevention of Cognitive Impairment in Patients With Atrial Fibrillation. Canadian Journal of Cardiology 2017;33:1556-64. [DOI: 10.1016/j.cjca.2017.09.024] [Cited by in Crossref: 36] [Cited by in F6Publishing: 26] [Article Influence: 7.2] [Reference Citation Analysis]
35 Watson T, Shantsila E, Lip GY. Pharmacotherapy for atrial fibrillation: is rhythm control achievable? Expert Opin Pharmacother 2006;7:1105-7. [PMID: 16732697 DOI: 10.1517/14656566.7.9.1105] [Reference Citation Analysis]
36 Khaykin Y, Oosthuizen R, Zarnett L, Wulffhart ZA, Whaley B, Hill C, Giewercer D, Verma A. CARTO-guided vs. NavX-guided pulmonary vein antrum isolation and pulmonary vein antrum isolation performed without 3-D mapping: effect of the 3-D mapping system on procedure duration and fluoroscopy time. J Interv Card Electrophysiol. 2011;30:233-240. [PMID: 21253840 DOI: 10.1007/s10840-010-9538-9] [Cited by in Crossref: 45] [Cited by in F6Publishing: 29] [Article Influence: 4.1] [Reference Citation Analysis]
37 Gleason KT, Dennison Himmelfarb CR, Ford DE, Lehmann H, Samuel L, Jain S, Naccarelli G, Aggarwal V, Nazarian S. Association of sex and atrial fibrillation therapies with patient-reported outcomes. Heart 2019;105:1642-8. [PMID: 31118198 DOI: 10.1136/heartjnl-2019-314881] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
38 Conway EL, Musco S, Kowey PR. Drug Therapy for Atrial Fibrillation. Cardiology Clinics 2009;27:109-23. [DOI: 10.1016/j.ccl.2008.10.003] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
39 Abete P, Della-morte D, Gargiulo G, Basile C, Langellotto A, Galizia G, Testa G, Canonico V, Bonaduce D, Cacciatore F. Cognitive impairment and cardiovascular diseases in the elderly. A heart–brain continuum hypothesis. Ageing Research Reviews 2014;18:41-52. [DOI: 10.1016/j.arr.2014.07.003] [Cited by in Crossref: 89] [Cited by in F6Publishing: 81] [Article Influence: 11.1] [Reference Citation Analysis]
40 Vilvanathan VK, Srinivas Prabhavathi Bhat BC, Nanjappa MC, Pandian B, Bagi V, Kasturi S, Bandimida SK. A randomized placebo-controlled trial with amiodarone for persistent atrial fibrillation in rheumatic mitral stenosis after successful balloon mitral valvuloplasty. Indian Heart J 2016;68:671-7. [PMID: 27773406 DOI: 10.1016/j.ihj.2016.02.013] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
41 Regaira-martínez E, Moro-tejedor M. Antiarrítmicos para mantener el ritmo sinusal tras la cardioversión en la fibrilación auricular. Enfermería Intensiva 2022. [DOI: 10.1016/j.enfi.2022.03.002] [Reference Citation Analysis]
42 Mörtsell D, Arbelo E, Dagres N, Brugada J, Laroche C, Trines SA, Malmborg H, Höglund N, Tavazzi L, Pokushalov E, Stabile G, Blomström-lundqvist C; ESC-EHRA Atrial Fibrillation Ablation Long-Term Registry investigators. Cryoballoon vs. radiofrequency ablation for atrial fibrillation: a study of outcome and safety based on the ESC-EHRA atrial fibrillation ablation long-term registry and the Swedish catheter ablation registry. EP Europace 2019;21:581-9. [DOI: 10.1093/europace/euy239] [Cited by in Crossref: 37] [Cited by in F6Publishing: 27] [Article Influence: 9.3] [Reference Citation Analysis]
43 Quinn TJ. What's good for the heart is good for the mind. . . Age Ageing 2022;51:afac021. [PMID: 35258517 DOI: 10.1093/ageing/afac021] [Reference Citation Analysis]
44 Ling LH, Kistler PM, Kalman JM, Schilling RJ, Hunter RJ. Comorbidity of atrial fibrillation and heart failure. Nat Rev Cardiol 2016;13:131-47. [PMID: 26658575 DOI: 10.1038/nrcardio.2015.191] [Cited by in Crossref: 84] [Cited by in F6Publishing: 71] [Article Influence: 12.0] [Reference Citation Analysis]
45 Goyal P, Rich MW. Electrophysiology and heart rhythm disorders in older adults. J Geriatr Cardiol 2016;13:645-51. [PMID: 27781053 DOI: 10.11909/j.issn.1671-5411.2016.08.001] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
46 Stegmann C, Hindricks G. Atrial Fibrillation in Heart Failure-Diagnostic, Therapeutic, and Prognostic Relevance. Curr Heart Fail Rep 2019;16:108-15. [PMID: 31144245 DOI: 10.1007/s11897-019-00430-5] [Reference Citation Analysis]
47 Conraads VM, Spruit MA, Braunschweig F, Cowie MR, Tavazzi L, Borggrefe M, Hill MR, Jacobs S, Gerritse B, van Veldhuisen DJ. Physical activity measured with implanted devices predicts patient outcome in chronic heart failure. Circ Heart Fail 2014;7:279-87. [PMID: 24519908 DOI: 10.1161/CIRCHEARTFAILURE.113.000883] [Cited by in Crossref: 51] [Cited by in F6Publishing: 31] [Article Influence: 6.4] [Reference Citation Analysis]
48 Lip GY, Laroche C, Boriani G, Cimaglia P, Dan G, Santini M, Kalarus Z, Rasmussen LH, Popescu MI, Tica O, Hellum CF, Mortensen B, Tavazzi L, Maggioni AP. Sex-related differences in presentation, treatment, and outcome of patients with atrial fibrillation in Europe: a report from the Euro Observational Research Programme Pilot survey on Atrial Fibrillation. EP Europace 2015;17:24-31. [DOI: 10.1093/europace/euu155] [Cited by in Crossref: 95] [Cited by in F6Publishing: 80] [Article Influence: 11.9] [Reference Citation Analysis]
49 Bajpai A, Savelieva I, Camm AJ. Treatment of atrial fibrillation. Br Med Bull 2008;88:75-94. [PMID: 19059992 DOI: 10.1093/bmb/ldn046] [Cited by in Crossref: 30] [Cited by in F6Publishing: 24] [Article Influence: 2.1] [Reference Citation Analysis]
50 Lin J, Li C, Chen Y, Weng C, Chien Y, Wu S, Lo C, Tien H, Lin C, Huang J, Lin Y, Hsieh Y, Chen S. Rhythm Control Better Prevents Dementia than Rate Control Strategies in Patients with Atrial Fibrillation—A Nationwide Cohort Study. JPM 2022;12:572. [DOI: 10.3390/jpm12040572] [Reference Citation Analysis]
51 Krishnamoorthy S, Lip GY. Antiarrhythmic drugs for atrial fibrillation: focus on dronedarone. Expert Review of Cardiovascular Therapy 2014;7:473-81. [DOI: 10.1586/erc.09.14] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
52 Kosior DA, Szulc M, Opolski G, Torbicki A, Rabczenko D. Long-term sinus rhythm maintenance after cardioversion of persistent atrial fibrillation: is the treatment's success predictable? Heart Vessels 2006;21:375-81. [DOI: 10.1007/s00380-006-0915-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
53 McCabe JM, Johnson CJ, Marcus GM. Internal medicine physicians' perceptions regarding rate versus rhythm control for atrial fibrillation. Am J Cardiol 2009;103:535-9. [PMID: 19195516 DOI: 10.1016/j.amjcard.2008.10.017] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
54 Proietti M, Romiti GF, Olshansky B, Lane DA, Lip GYH. Improved Outcomes by Integrated Care of Anticoagulated Patients with Atrial Fibrillation Using the Simple ABC (Atrial Fibrillation Better Care) Pathway. Am J Med 2018;131:1359-1366.e6. [PMID: 30153428 DOI: 10.1016/j.amjmed.2018.06.012] [Cited by in Crossref: 63] [Cited by in F6Publishing: 58] [Article Influence: 15.8] [Reference Citation Analysis]
55 Suman-Horduna I, Roy D, Frasure-Smith N, Talajic M, Lespérance F, Blondeau L, Dorian P, Khairy P. Quality of life and functional capacity in patients with atrial fibrillation and congestive heart failure. J Am Coll Cardiol. 2013;61:455-460. [PMID: 23265334 DOI: 10.1016/j.jacc.2012.10.031] [Cited by in Crossref: 64] [Cited by in F6Publishing: 53] [Article Influence: 6.4] [Reference Citation Analysis]
56 Aldrugh S, Sardana M, Henninger N, Saczynski JS, McManus DD. Atrial fibrillation, cognition and dementia: A review. J Cardiovasc Electrophysiol 2017;28:958-65. [PMID: 28569383 DOI: 10.1111/jce.13261] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 7.0] [Reference Citation Analysis]
57 Bodagh N, Yap R, Kotadia I, Sim I, Bhalla A, Somerville P, O'Neill M, Williams SE. Impact of catheter ablation versus medical therapy on cognitive function in atrial fibrillation: a systematic review. J Interv Card Electrophysiol 2022. [PMID: 35380337 DOI: 10.1007/s10840-022-01196-y] [Reference Citation Analysis]
58 Benenati S, Canale C, De Marzo V, Della Bona R, Rosa GM, Porto I. Atrial fibrillation and Alzheimer's disease: A conundrum. Eur J Clin Invest 2021;51:e13451. [PMID: 33219514 DOI: 10.1111/eci.13451] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
59 Kim D, Yang P, You SC, Sung J, Jang E, Yu HT, Kim T, Pak H, Lee M, Lip GYH, Joung B. Association of rhythm control with incident dementia among patients with atrial fibrillation: a nationwide population-based cohort study. Age and Ageing 2022;51:afab248. [DOI: 10.1093/ageing/afab248] [Reference Citation Analysis]
60 Ibrahim OA, Belley-Côté EP, Um KJ, Baranchuk A, Benz AP, Dalmia S, Wang CN, Alhazzani W, Conen D, Devereaux PJ, Whitlock RP, Healey JS, McIntyre WF. Single-dose oral anti-arrhythmic drugs for cardioversion of recent-onset atrial fibrillation: a systematic review and network meta-analysis of randomized controlled trials. Europace 2021:euab014. [PMID: 33723602 DOI: 10.1093/europace/euab014] [Reference Citation Analysis]
61 Salih M, Abdel-Hafez O, Ibrahim R, Nair R. Atrial fibrillation in the elderly population: Challenges and management considerations. J Arrhythm 2021;37:912-21. [PMID: 34386117 DOI: 10.1002/joa3.12580] [Reference Citation Analysis]
62 Plisiene J, Blumberg A, Haager G, Knackstedt C, Latsch J, Norra C, Arndt M, Tuerk S, Heussen N, Kelm M, Predel HG, Schauerte P. Moderate physical exercise: a simplified approach for ventricular rate control in older patients with atrial fibrillation. Clin Res Cardiol 2008;97:820-6. [DOI: 10.1007/s00392-008-0692-3] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 1.7] [Reference Citation Analysis]
63 Wyse DG. Pharmacotherapy for rhythm management in elderly patients with atrial fibrillation. J Interv Card Electrophysiol 2009;25:25-9. [DOI: 10.1007/s10840-008-9329-8] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
64 Lip GY, Tse H. Management of atrial fibrillation. The Lancet 2007;370:604-18. [DOI: 10.1016/s0140-6736(07)61300-2] [Cited by in Crossref: 141] [Cited by in F6Publishing: 44] [Article Influence: 9.4] [Reference Citation Analysis]
65 Al-Khatib SM, Alexander JH, Lopes RD, Mahaffey KW, Patel MR, Granger CB. Promise of factor Xa inhibition in atrial fibrillation. Curr Cardiol Rep 2012;14:70-8. [PMID: 22109539 DOI: 10.1007/s11886-011-0230-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
66 Gross AF, Stern TA. The cognitive impact of atrial fibrillation. Prim Care Companion CNS Disord 2013;15:PCC. [PMID: 23724342 DOI: 10.4088/PCC.12f01471] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
67 Zivin A. Measuring success in atrial fibrillation: Groping the elephant. Heart Rhythm 2010;7:602-3. [PMID: 20170771 DOI: 10.1016/j.hrthm.2010.01.022] [Reference Citation Analysis]
68 Reiffel JA. Atrial Fibrillation: What Have Recent Trials Taught Us Regarding Pharmacologic Management of Rate and Rhythm Control?: REVIEW OF RECENT TRIALS IN AF. Pacing and Clinical Electrophysiology 2011;34:247-59. [DOI: 10.1111/j.1540-8159.2010.02967.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
69 Buber J, Glikson M, Eldar M, Luria D. Exercise heart rate acceleration patterns during atrial fibrillation and sinus rhythm. Ann Noninvasive Electrocardiol 2011;16:357-64. [PMID: 22008491 DOI: 10.1111/j.1542-474X.2011.00463.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
70 Walkey AJ, Hogarth DK, Lip GYH. Optimizing atrial fibrillation management: from ICU and beyond. Chest 2015;148:859-64. [PMID: 25951122 DOI: 10.1378/chest.15-0358] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 5.5] [Reference Citation Analysis]
71 Rienstra M, Lubitz SA, Mahida S, Magnani JW, Fontes JD, Sinner MF, Van Gelder IC, Ellinor PT, Benjamin EJ. Symptoms and functional status of patients with atrial fibrillation: state of the art and future research opportunities. Circulation 2012;125:2933-43. [PMID: 22689930 DOI: 10.1161/CIRCULATIONAHA.111.069450] [Cited by in Crossref: 92] [Cited by in F6Publishing: 44] [Article Influence: 9.2] [Reference Citation Analysis]
72 Tobón C, Palacio LC, Chidipi B, Slough DP, Tran T, Tran N, Reiser M, Lin YS, Herweg B, Sayad D, Saiz J, Noujaim S. The Antimalarial Chloroquine Reduces the Burden of Persistent Atrial Fibrillation. Front Pharmacol 2019;10:1392. [PMID: 31827438 DOI: 10.3389/fphar.2019.01392] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
73 Steinberg BA, Broderick SH, Lopes RD, Shaw LK, Thomas KL, DeWald TA, Daubert JP, Peterson ED, Granger CB, Piccini JP. Use of antiarrhythmic drug therapy and clinical outcomes in older patients with concomitant atrial fibrillation and coronary artery disease. Europace 2014;16:1284-90. [PMID: 24755440 DOI: 10.1093/europace/euu077] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
74 Khaykin Y, Zarnett L, Friedlander D, Wulffhart ZA, Whaley B, Giewercer D, Tsang B, Verma A. Point-by-point pulmonary vein antrum isolation guided by intracardiac echocardiography and 3D mapping and duty-cycled multipolar AF ablation: effect of multipolar ablation on procedure duration and fluoroscopy time. J Interv Card Electrophysiol 2012;34:303-10. [DOI: 10.1007/s10840-012-9676-3] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
75 Camm AJ, Blomström-Lundqvist C, Boriani G, Goette A, Kowey PR, Merino JL, Piccini JP, Saksena S, Reiffel JA. AIM-AF: A Physician Survey in the United States and Europe. J Am Heart Assoc 2022;:e023838. [PMID: 35243874 DOI: 10.1161/JAHA.121.023838] [Reference Citation Analysis]
76 Hsieh Y, Chen Y, Chien K, Chung F, Lo L, Chang S, Chao T, Hu Y, Lin C, Tuan T, Liao J, Lin Y, Chen S. Catheter ablation of atrial fibrillation reduces the risk of dementia and hospitalization during a very long-term follow-up. International Journal of Cardiology 2020;304:75-81. [DOI: 10.1016/j.ijcard.2019.12.016] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
77 Chopard R, Piazza G, Gale SA, Campia U, Albertsen IE, Kim J, Goldhaber SZ. Dementia and Atrial Fibrillation: Pathophysiological Mechanisms and Therapeutic Implications. The American Journal of Medicine 2018;131:1408-17. [DOI: 10.1016/j.amjmed.2018.06.035] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 4.3] [Reference Citation Analysis]
78 Frendl G, Sodickson AC, Chung MK, Waldo AL, Gersh BJ, Tisdale JE, Calkins H, Aranki S, Kaneko T, Cassivi S, Smith SC Jr, Darbar D, Wee JO, Waddell TK, Amar D, Adler D; American Association for Thoracic Surgery. 2014 AATS guidelines for the prevention and management of perioperative atrial fibrillation and flutter for thoracic surgical procedures. J Thorac Cardiovasc Surg 2014;148:e153-93. [PMID: 25129609 DOI: 10.1016/j.jtcvs.2014.06.036] [Cited by in Crossref: 144] [Cited by in F6Publishing: 98] [Article Influence: 18.0] [Reference Citation Analysis]
79 Reiffel JA. Rate Versus Rhythm Control Pharmacotherapy For Atrial Fibrillation: Where are We in 2008? J Atr Fibrillation 2008;1:21. [PMID: 28496569 DOI: 10.4022/jafib.21] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
80 Falk RH. Atrial Fibrillation or Sinus Rhythm? Journal of the American College of Cardiology 2006;48:731-3. [DOI: 10.1016/j.jacc.2006.05.022] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
81 Shah S, Raj V, Abdelghany M, Mena-Hurtado C, Riaz S, Patel S, Wiener H, Chaudhuri D. Impact of atrial fibrillation on the outcomes of transcatheter mitral valve repair using MitraClip: a systematic review and meta-analysis. Heart Fail Rev 2021;26:531-43. [PMID: 33169339 DOI: 10.1007/s10741-020-10051-z] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
82 Alagiakrishnan K, Banach M, Mah D, Ahmed A, Aronow WS. Role of Geriatric Syndromes in the Management of Atrial Fibrillation in Older Adults: A Narrative Review. J Am Med Dir Assoc 2019;20:123-30. [PMID: 30270028 DOI: 10.1016/j.jamda.2018.07.021] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
83 Ihara M, Washida K. Linking Atrial Fibrillation with Alzheimer's Disease: Epidemiological, Pathological, and Mechanistic Evidence. J Alzheimers Dis 2018;62:61-72. [PMID: 29439352 DOI: 10.3233/JAD-170970] [Cited by in Crossref: 32] [Cited by in F6Publishing: 15] [Article Influence: 10.7] [Reference Citation Analysis]
84 Theunissen LJHJ, Cremers H, Veghel D, Voort PH, Polak PE, Jong SFAMS, Smits G, Dijkmans J, Kemps HMC, Dekker L, Pol JAA. Age‐dependency of EHRA improvement based on quality of life at diagnosis of atrial fibrillation. Journal of Arrhythmia. [DOI: 10.1002/joa3.12671] [Reference Citation Analysis]
85 Rienstra M, Lyass A, Murabito JM, Magnani JW, Lubitz SA, Massaro JM, Ellinor PT, Benjamin EJ. Reciprocal relations between physical disability, subjective health, and atrial fibrillation: the Framingham Heart Study. Am Heart J 2013;166:171-8. [PMID: 23816037 DOI: 10.1016/j.ahj.2013.02.025] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
86 Damanti S, Pasina L, Cortesi L, Rossi PD, Cesari M. Atrial Fibrillation: Possible Influences of Rate and Rhythm Control Strategy on Cognitive Performance. J Am Geriatr Soc 2018;66:2178-82. [PMID: 30281781 DOI: 10.1111/jgs.15568] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
87 Kato N, Muraga K, Hirata Y, Shindo A, Matsuura K, Ii Y, Shiga M, Tabei KI, Satoh M, Fujita S, Fukuma T, Kagawa Y, Fujii E, Umino M, Maeda M, Sakuma H, Ito M, Tomimoto H. Brain magnetic resonance imaging and cognitive alterations after ablation in patients with atrial fibrillation. Sci Rep 2021;11:18995. [PMID: 34556757 DOI: 10.1038/s41598-021-98484-w] [Reference Citation Analysis]
88 Zhang Y, Qiu C, Davis PJ, Jhaveri M, Prystowsky EN, Kowey P, Weintraub WS. Predictors of Progression of Recently Diagnosed Atrial Fibrillation in REgistry on Cardiac Rhythm DisORDers Assessing the Control of Atrial Fibrillation (RecordAF)–United States Cohort. The American Journal of Cardiology 2013;112:79-84. [DOI: 10.1016/j.amjcard.2013.02.056] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 2.1] [Reference Citation Analysis]
89 Allen Lapointe NM, Sun JL, Kaplan S, d'Almada P, Al-Khatib SM. Rhythm versus rate control in the contemporary management of atrial fibrillation in-hospital. Am J Cardiol 2008;101:1134-41. [PMID: 18394447 DOI: 10.1016/j.amjcard.2007.11.067] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
90 Yoo S, Pfenniger A, Hoffman J, Zhang W, Ng J, Burrell A, Johnson DA, Gussak G, Waugh T, Bull S, Benefield B, Knight BP, Passman R, Wasserstrom JA, Aistrup GL, Arora R. Attenuation of Oxidative Injury With Targeted Expression of NADPH Oxidase 2 Short Hairpin RNA Prevents Onset and Maintenance of Electrical Remodeling in the Canine Atrium: A Novel Gene Therapy Approach to Atrial Fibrillation. Circulation 2020;142:1261-78. [DOI: 10.1161/circulationaha.119.044127] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
91 Lane DA, Aguinaga L, Blomström-Lundqvist C, Boriani G, Dan GA, Hills MT, Hylek EM, LaHaye SA, Lip GY, Lobban T, Mandrola J, McCabe PJ, Pedersen SS, Pisters R, Stewart S, Wood K, Potpara TS, Gorenek B, Conti JB, Keegan R, Power S, Hendriks J, Ritter P, Calkins H, Violi F, Hurwitz J. Cardiac tachyarrhythmias and patient values and preferences for their management: the European Heart Rhythm Association (EHRA) consensus document endorsed by the Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE). Europace 2015;17:1747-69. [PMID: 26108807 DOI: 10.1093/europace/euv233] [Cited by in Crossref: 87] [Cited by in F6Publishing: 86] [Article Influence: 12.4] [Reference Citation Analysis]
92 Krishnamoorthy S, Lip GY. Novel antiarrhythmic drugs in atrial fibrillation: focus on tedisamil. Expert Opinion on Investigational Drugs 2009;18:1191-6. [DOI: 10.1517/13543780903114150] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
93 Tini G, Scagliola R, Monacelli F, La Malfa G, Porto I, Brunelli C, Rosa GM. Alzheimer's Disease and Cardiovascular Disease: A Particular Association. Cardiol Res Pract 2020;2020:2617970. [PMID: 32454996 DOI: 10.1155/2020/2617970] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 7.0] [Reference Citation Analysis]
94 Ad N, Henry L, Hunt S. The impact of surgical ablation in patients with low ejection fraction, heart failure, and atrial fibrillation. Eur J Cardiothorac Surg. 2011;40:70-76. [PMID: 21169029 DOI: 10.1016/j.ejcts.2010.11.016] [Cited by in Crossref: 41] [Cited by in F6Publishing: 44] [Article Influence: 3.4] [Reference Citation Analysis]
95 Guglin M, Chen R. How much atrial fibrillation causes symptoms of heart failure? Int J Clin Pract 2014;68:453-7. [PMID: 24373100 DOI: 10.1111/ijcp.12262] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
96 Rasmussen PV, Pallisgaard JL, Hansen ML, Gislason GH, Torp-Pedersen C, Ruwald M, Alexander KP, Lopes RD, Al-Khatib SM, Dalgaard F. Treatment of Older Patients with Atrial Fibrillation by Morbidity Burden. Eur Heart J Qual Care Clin Outcomes 2020:qcaa070. [PMID: 32857834 DOI: 10.1093/ehjqcco/qcaa070] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
97 Manolis TA, Manolis AA, Apostolopoulos EJ, Melita H, Manolis AS. Atrial Fibrillation and Cognitive Impairment: An Associated Burden or Burden by Association? Angiology 2020;71:498-519. [DOI: 10.1177/0003319720910669] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
98 Mahmood M, Lip GY. Management of atrial fibrillation: easy as ABC. Minerva Med 2019;110. [DOI: 10.23736/s0026-4806.18.05824-x] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]